Trastuzumab. Monoclonal antibody for the treatment of breast cancer
Heinzl, S.
Medizinische Monatsschrift für Pharmazeuten 23(11): 350-352
2000
ISSN/ISBN: 0342-9601 PMID: 11103587 Document Number: 525239
Document emailed within 1 workday
Related Documents
Altundag, K. 2017: Predictive markers for trastuzumab-associated cardiac dysfunction in patients with early-stage human epidermal growth factor receptor 2-positive breast cancer receiving trastuzumab Journal of BUON: Official Journal of the Balkan Union of Oncology 22(3): 801Chakraborty, M.; Mukerjee, S.; Foon, K.A.; Köhler, H.; Ceriani, R.L.; Bhattacharya-Chatterjee, M. 1995: Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody Cancer Research 55(7): 1525-1530
Murray, J.L.; Macey, D.J.; Grant, E.J.; Rosenblum, M.G.; Kasi, L.P.; Zhang, H.Z.; Katz, R.L.; Riger, P.T.; LeBherz, D.; Bhadkamkar, V. 1995: Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment Cancer Research 55(23 Suppl): 5925s-5928s
Wang, Y.; Li, J-jie.; Di, G-hong.; Lu, J-song.; Wu, J.; Liu, G-yu.; Hu, X-chun.; Wang, Z-hua.; Yang, W-tao.; Shao, Z-min. 2010: Retrospective analysis of trastuzumab treatment in 141 patients with Her-2 positive breast cancer Zhonghua Zhong Liu Za Zhi 32(11): 864-867
Edwards, D.P.; Grzyb, K.T.; Dressler, L.G.; Mansel, R.E.; Zava, D.T.; Sledge, G.W.; McGuire, W.L. 1986: Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer Cancer Research 46(3): 1306-1317
Giai, M.; Natoli, C.; Sismondi, P.; Biglia, N.; Lesti, G.; Mulieri, M.; Iacobelli, S. 1990: Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer Anticancer Research 10(1): 119-121
Stacker, S.A.; Thompson, C.H.; Sacks, N.P.; Tjandra, J.; Lowe, M.G.; Bishop, J.; McKenzie, I.F. 1988: Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2 Cancer Research 48(24 Part 1): 7060-7066
Hendler, F.J.; Yuan, D. 1985: Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer Cancer Research 45(1): 421-429
Ohsako, T.; Inoue, K.; Nagamoto, N.; Yoshida, Y.; Nakahara, O. 2006: Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(9): 1301-1303
Ohnami, S.; Nakayama, C.; Ohnami, S.; Zeze, F.; Eto, S. 1986: Enzyme immunoassay and radioimmunoassay using monoclonal antibody for the determination of estrogen receptors in human breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(12): 3447-3452
Kimura, M.; Sano, M.; Tabei, T.; Asaga, T.; Ando, J.; Fujii, H.; Yamamoto, N.; Kurosumi, M. 2005: Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 335-339
Rudlowski, C.; Rath, W.; Becker, A.J.; Wiestler, O.D.; Buttner, R. 2001: Trastuzumab and breast cancer New England Journal of Medicine 345(13): 997-998
Blottière, H.M.; Douillard, J.Y.; Koprowski, H.; Steplewski, Z. 1990: Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients Cancer Research 50(3 Suppl): 1051s-1054s
Morton, B.A.; Ramey, W.G.; Paderon, H.; Miller, R.E. 1986: Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer Cancer Research 46(4 Part 2): 2121-2126
Koukourakis, M.I.; Simopoulos, C.; Polychronidis, A.; Perente, S.; Botaitis, S.; Giatromanolaki, A.; Sivridis, E. 2003: The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: dichotomus effect predictable by the HIFi alpha/VEGF pre-treatment status? Anticancer Research 23(2c): 1673-1680
Murphy, C.G.; Fornier, M. 2010: HER2-positive breast cancer: beyond trastuzumab Oncology 24(5): 410-415
Vold, B.S.; Kraus, L.E.; Rimer, V.G.; Coombes, R.C. 1986: Use of a monoclonal antibody to detect elevated levels of a modified nucleoside, N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, in the urine of breast cancer patients Cancer Research 46(6): 3164-3167
Nicol, M.; Baudet, M.; Cohen Solal, A. 2018: Acute dyspnea after trastuzumab-treated breast cancer La Revue du Praticien 68(3): 303-306
Gasparini, G.; Pozza, F.; Meli, S.; Reitano, M.; Santini, G.; Bevilacqua, P. 1991: Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness Anticancer Research 11(6): 2015-2021
Melner, M.H.; Voigt, W.; Puett, D. 1986: Cross-reactivity of a monoclonal antibody directed against an estrogen-induced protein in MCF-7 human breast cancer cells with murine Leydig cell tumor proteins Cancer Research 46(1): 328-331